Work

Impact of pre-infusion disease burden on outcomes in pediatric relapsed/refractory B-cell lymphoblastic leukemia following anti-CD19 CAR T-cell therapy

FWCI: 0.766
Cites: 31
Cited by: 5
Related to: 10